Research biobanks are non-profit structures that collect, manipulate, store, analyze and distribute systematically organized biological samples and data for research and development purposes. Over the recent years, we have established a biobank, the Rheumatology BioBank (RheumaBank) headed by the Medicine and Rheumatology unit of the IRCCS Istituto Ortopedico Rizzoli (IOR) in Bologna, Italy for the purpose of collecting, processing, storing, and distributing biological samples and associated data obtained from patients suffering from inflammatory joint diseases. RheumaBank is a research biobank, and its main objective is to promote large-scale, high-quality basic, translational, and clinical research studies that can help elucidate pathogenetic mechanisms and improve personalization of treatment choice in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other spondyloarthritides (SpA).

Assirelli E., Naldi S., Brusi V., Ciaffi J., Lisi L., Mancarella L., et al. (2023). Building a rheumatology biobank for reliable basic/translational research and precision medicine. FRONTIERS IN MEDICINE, 10, 1-10 [10.3389/fmed.2023.1228874].

Building a rheumatology biobank for reliable basic/translational research and precision medicine

Assirelli E.;Brusi V.;Ciaffi J.;Pignatti F.;Faldini C.;Ursini F.
;
2023

Abstract

Research biobanks are non-profit structures that collect, manipulate, store, analyze and distribute systematically organized biological samples and data for research and development purposes. Over the recent years, we have established a biobank, the Rheumatology BioBank (RheumaBank) headed by the Medicine and Rheumatology unit of the IRCCS Istituto Ortopedico Rizzoli (IOR) in Bologna, Italy for the purpose of collecting, processing, storing, and distributing biological samples and associated data obtained from patients suffering from inflammatory joint diseases. RheumaBank is a research biobank, and its main objective is to promote large-scale, high-quality basic, translational, and clinical research studies that can help elucidate pathogenetic mechanisms and improve personalization of treatment choice in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other spondyloarthritides (SpA).
2023
Assirelli E., Naldi S., Brusi V., Ciaffi J., Lisi L., Mancarella L., et al. (2023). Building a rheumatology biobank for reliable basic/translational research and precision medicine. FRONTIERS IN MEDICINE, 10, 1-10 [10.3389/fmed.2023.1228874].
Assirelli E.; Naldi S.; Brusi V.; Ciaffi J.; Lisi L.; Mancarella L.; Pignatti F.; Pulsatelli L.; Faldini C.; Ursini F.; Neri S.
File in questo prodotto:
File Dimensione Formato  
Frontiers in Medicine 2023b.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.91 MB
Formato Adobe PDF
1.91 MB Adobe PDF Visualizza/Apri
Data Sheet 1 (1).docx

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 829.13 kB
Formato Microsoft Word XML
829.13 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/957216
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact